Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2014

Feb 14, 2014

30583_dirs_2014-02-14_bb72705d-961a-4dcd-a2c2-633a46474c23.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-12-31

Reporting Person: BAFFI ROBERT (EVP, Technical Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-05-14 Common Stock G 1912 Disposed 60350 Direct
2013-05-14 Common Stock G 1912 Acquired 10955 Indirect
2013-10-31 Common Stock A 92 $27.9055 Acquired 60422 Direct
2013-11-13 Common Stock G 92 Disposed 60350 Direct
2013-11-13 Common Stock G 92 Acquired 11047 Indirect

Footnotes

F1: On May 14, 2013 the reporting person gifted 1,912 shares of Common Stock to his family trust. The reporting person is the trustee.

F2: The reporting person is reporting the acquisition of shares of issuer's Employee Stock Purchase Plan ("ESPP")for the ESPP purchase period of May 1, 2013 to Octobr 31, 2013.

F3: On November 13, 2013 the reporting person gifted 92 shares of Common Stock to his family trust. The reporting person is the trustee.